ADMA Biologics Inc (ADMA)
6.54
+0.34
(+5.48%)
USD |
NASDAQ |
Apr 23, 16:00
6.50
-0.04
(-0.61%)
After-Hours: 05:01
ADMA Biologics Debt to Equity Ratio: 0.9659 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.9659 |
| September 30, 2023 | 0.9379 |
| June 30, 2023 | 0.956 |
| March 31, 2023 | 0.9907 |
| December 31, 2022 | 0.9399 |
| September 30, 2022 | 1.408 |
| June 30, 2022 | 1.222 |
| March 31, 2022 | 1.090 |
| December 31, 2021 | 0.672 |
| September 30, 2021 | 0.9181 |
| June 30, 2021 | 0.8412 |
| March 31, 2021 | 0.8303 |
| December 31, 2020 | 1.054 |
| September 30, 2020 | 1.360 |
| June 30, 2020 | 1.256 |
| March 31, 2020 | 0.9979 |
| December 31, 2019 | 3.176 |
| September 30, 2019 | 2.291 |
| June 30, 2019 | 1.756 |
| March 31, 2019 | 5.555 |
| December 31, 2018 | 2.229 |
| September 30, 2018 | 1.177 |
| June 30, 2018 | 0.8404 |
| March 31, 2018 | 1.877 |
| Date | Value |
|---|---|
| December 31, 2017 | 1.065 |
| September 30, 2017 | 2.398 |
| June 30, 2017 | 1.179 |
| March 31, 2017 | -1.794 |
| December 31, 2016 | -4.537 |
| September 30, 2016 | -131.65 |
| June 30, 2016 | 5.066 |
| March 31, 2016 | -4.693 |
| December 31, 2015 | 19.10 |
| September 30, 2015 | 3.164 |
| June 30, 2015 | 1.620 |
| March 31, 2015 | 1.119 |
| December 31, 2014 | 2.447 |
| September 30, 2014 | 1.081 |
| June 30, 2014 | 0.7998 |
| March 31, 2014 | 0.6166 |
| December 31, 2013 | 0.2317 |
| September 30, 2013 | -6.759 |
| June 30, 2013 | 2.864 |
| March 31, 2013 | 0.7697 |
| December 31, 2012 | 0.4117 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.672
Minimum
Dec 2021
3.176
Maximum
Dec 2019
1.245
Average
0.9979
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Vanda Pharmaceuticals Inc | 0.00 |
| ANI Pharmaceuticals Inc | 0.6243 |
| Ligand Pharmaceuticals Inc | 0.00 |
| Puma Biotechnology Inc | 1.865 |
| Bristol-Myers Squibb Co | 1.351 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 329.18M |
| Total Liabilities (Quarterly) | 193.98M |
| Shareholders Equity (Quarterly) | 135.21M |
| Current Ratio | 5.160 |
| Net Debt Paydown Yield | 0.21% |